Redhawk Wealth Advisors Inc. Buys 3,651 Shares of SPDR S&P Biotech ETF $XBI

Redhawk Wealth Advisors Inc. boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 18.1% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 23,790 shares of the exchange traded fund’s stock after purchasing an additional 3,651 shares during the period. Redhawk Wealth Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,765,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Axiom Investment Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the first quarter worth about $26,000. Financial Life Planners bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $27,000. Intesa Sanpaolo Wealth Management bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $30,000. Finally, SHP Wealth Management purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth approximately $31,000.

SPDR S&P Biotech ETF Trading Up 0.4%

NYSEARCA XBI opened at $158.03 on Tuesday. SPDR S&P Biotech ETF has a 12 month low of $84.81 and a 12 month high of $165.71. The stock has a market cap of $10.32 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The company’s 50 day moving average is $148.49 and its two-hundred day moving average is $135.64.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.